Palisade Bio, Inc.
PALI
$0.6902
-$0.0638-8.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -14.12% | 4.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.07% | -31.70% | |||
| Operating Income | -23.07% | 31.70% | |||
| Income Before Tax | -24.84% | 33.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -24.84% | 33.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.84% | 33.31% | |||
| EBIT | -23.07% | 31.70% | |||
| EBITDA | -23.08% | 31.73% | |||
| EPS Basic | -24.80% | 69.95% | |||
| Normalized Basic EPS | -24.81% | 69.95% | |||
| EPS Diluted | -24.80% | 69.95% | |||
| Normalized Diluted EPS | -24.81% | 69.95% | |||
| Average Basic Shares Outstanding | 0.03% | 121.91% | |||
| Average Diluted Shares Outstanding | 0.03% | 121.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||